Stockreport

Alumis Announces Pricing of Initial Public Offering

Alumis Inc.  (ALMS) 
PDF SOUTH SAN FRANCISCO, Calif., June 27, 2024 (GLOBE NEWSWIRE) -- Alumis Inc. (“Alumis” or the “Company”) (Nasdaq: ALMS), a clinical-stage biopharmaceutical company devel [Read more]